Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | VTGN Vistagen Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.28 -8.8% | $15.90 -2.5% |
| StockIQ Score | 54C- Moderate Risk: High | 41D Weak Risk: High |
| Technical | 68B- | 36F |
| Fundamental | 30F | 35F |
| Growth | 46D+ | 50C- |
| Fair Value | 55C | 38F |
| News | 100A+ | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
VTGN outperforms AAPG in investor confidence and technical strength, with scores of 54 and 68 versus 41 and 36. However, AAPG has a slightly higher growth score of 50 compared to VTGN’s 46. VTGN’s overall rating is moderate, while AAPG is rated weak. Fundamental and valuation scores favor VTGN (30 vs. 35 and 55 vs. 38).
